Cargando…

Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience

Screening for severe combined immunodeficiency (SCID) was added to the New Zealand national newborn screening programme in December 2017. Documentation pertaining to the application to add SCID to the panel and screening results over the first three years were reviewed. Screening evaluation metrics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heather, Natasha, de Hora, Mark, Brothers, Shannon, Grainger, Pippa, Knoll, Detlef, Webster, Dianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149990/ https://www.ncbi.nlm.nih.gov/pubmed/35645287 http://dx.doi.org/10.3390/ijns8020033

Ejemplares similares

The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening
por: Bernhardt, Isaac, et al.
Publicado: (2022)

Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results
por: Heather, Natasha, et al.
Publicado: (2022)

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020)

Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018)

The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives
por: de Hora, Mark, et al.
Publicado: (2023)

Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019)

Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

A Case of Severe Combined Immunodeficiency Missed by Newborn Screening
por: Kitcharoensakkul, Maleewan, et al.
Publicado: (2021)

A Call to Include Severe Combined Immunodeficiency in Newborn Screening Program
por: Somech, Raz, et al.
Publicado: (2014)

Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2022)

Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management
por: Dorsey, Morna, et al.
Publicado: (2017)

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK
por: Bessey, Alice, et al.
Publicado: (2019)

Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?
por: Mongkonsritragoon, Wimwipa, et al.
Publicado: (2023)

Genotype–phenotype correlations in CPT1A deficiency detected by newborn screening in Pacific populations
por: Bernhardt, Isaac, et al.
Publicado: (2022)

TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review
por: van der Spek, Jet, et al.
Publicado: (2015)

First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency—Clinical Achievements and Insights
por: Rechavi, Erez, et al.
Publicado: (2017)

A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
por: Al Sukaiti, Nashat, et al.
Publicado: (2021)

Newborn Screening for Severe Combined Immunodeficiency: Do Preterm Infants Require Special Consideration?
por: Atkins, Anne E., et al.
Publicado: (2021)

Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening
por: Raspa, Melissa, et al.
Publicado: (2023)

Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening
por: de Pagter, Anne P. J., et al.
Publicado: (2015)

NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCIES USING TRECS AND KRECS: SECOND PILOT STUDY IN BRAZIL
por: Kanegae, Marilia Pyles P., et al.
Publicado: (2017)

Development of a Population-Based Newborn Screening Method for Severe Combined Immunodeficiency in Manitoba, Canada
por: Thompson, J. Robert, et al.
Publicado: (2018)

Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases
por: Jilkina, O., et al.
Publicado: (2014)

Introducing and Expanding Newborn Screening in the MENA Region
por: Skrinska, Victor, et al.
Publicado: (2020)

Feasibility study assessing equitable delivery of newborn pulse oximetry screening in New Zealand’s midwifery-led maternity setting
por: Cloete, Elza, et al.
Publicado: (2019)

Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision Circles
por: Cogley, Michael F., et al.
Publicado: (2021)

IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY
por: Meehan, Cristina, et al.
Publicado: (2018)

Screening for severe combined immunodeficiency in neonates
por: Kelly, Brian T, et al.
Publicado: (2013)

A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay
por: Thakar, Monica S., et al.
Publicado: (2017)

First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2019)

It All Depends What You Count—The Importance of Definitions in Evaluation of CF Screening Performance
por: Heather, Natasha, et al.
Publicado: (2020)

Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
por: Strand, Janne, et al.
Publicado: (2020)

Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

Newborn Screening for CAH—Challenges and Opportunities
por: Heather, Natasha L., et al.
Publicado: (2021)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
por: Mantravadi, Vasudha, et al.
Publicado: (2021)

Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2021)

Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth
por: Chan, Su-Wan Bianca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_esjjhq1sj24g0br4vmber3iohv